Clomipramine
TCA • Last reviewed 2025-09-27
Brands: Anafranil
Sources updated 2025 • 1 references
General Information
Indicated for: Obsessive-compulsive disorder; treatment-resistant depression. TCA
Dosage & Administration
Typical dose range: 100–250 mg/day (divided)
Therapeutic level: Combined clomipramine + desmethylclomipramine 150–300 ng/mL.
Indications (label)
Obsessive-compulsive disorder; treatment-resistant depression.
View labelExact
Mechanism (brief)
Tricyclic antidepressant; potent serotonin reuptake inhibition with strong anticholinergic activity.
Metabolism & Half‑life
- Metabolism: CYP2D6/CYP3A4 to desmethylclomipramine.
- Half‑life: ~32–37 h.
Therapeutic Drug Monitoring (TDM)
Recommended: No
References
- Clomipramine labelExact (2025)